Mass-produced blood project threatened by stem cell ruling

Europe-wide ban on human embryo patents will drive away private investors, scientists fear

News in pictures
News in pictures
On Facebook
From the blogs

Manchester City top the ‘injury league’, with Manchester United bottom

The results of new research into every significant injury suffered by every Premier League footballe...

A Jubilee letter from a republican to royalists

With the Jubilee weekend edging ever nearer Rob Williams offers some help for those Royalists who ju...

Asylum seekers: When the questions tell us so much more than the answers

For the last four years I've been paying my karmic dues (I would say "contributing to the big societ...

GCSEs are a pointless waste of time

A few facts. Last year almost 70% of 16 year olds achieved at least 5 GCSE passes with grades A*-C. ...

A Europe-wide ban on patents derived from human embryonic stem cells threatens to undermine a pioneering British research project to produce industrial-scale quantities of synthetic blood for hospital transfusions.

The scientist in charge of an attempt to mass-produce human red blood cells from stem cells derived from spare IVF embryos said the European Court of Justice's patent ruling could force him to switch to non-embryonic stem cells.

A team of UK researchers, funded by the Wellcome Trust medical research charity, is trying to develop stem cells derived from spare IVF embryos to make large volumes of red blood cells for use in transfusions.

They have successfully produced oxygen-carrying red cells and are trying to scale up production to make industrial quantities of substitute blood, but will almost certainly need further investment from the private sector.

However, earlier this month the European Court of Justice ruled that it was not possible to patent inventions using human embryonic stem cells, a decision widely condemned by leading stem-cell scientists in Britain who argued that it would stymie private investment in this new area of medical research.

"Unfortunately it will make it less likely that companies in Europe will invest in the research to develop treatments to use embryonic stem cells for treatment of human diseases," said Professor Sir Ian Wilmut of Edinburgh University, who cloned Dolly the sheep.

Professor Marc Turner, director of the Scottish Blood Transfusion Service in Edinburgh, told The Independent that the ban on patents using human embryonic stem cells could also jeopardise his project on synthetic blood because it is likely to affect future investment by private organisations.

"The NHS is not in the business of developing products and to see this technology going forward we would need private investment. In the broadest sense, the patent ruling will have an impact on possible investment by the private sector," he said.

Rather than using stem cells derived from spare IVF embryos, the research team, based in Edinburgh and Glasgow, is considering shifting to stem cells derived from human adult cells that have been transformed genetically by a technique known as induced pluripotent stem (iPS) cells, he said.

"The ruling will have an effect in that we are now considering the possibility of adapting the project appropriately. We may move from embryonic stem cells to [non embryonic] iPS cells," Professor Turner explained.

The aim of the £3m project is to develop an alternative source of O-negative blood, the universal donor group that can be transfused into the vast majority of the population without fear of rejection.

More than 100 spare IVF embryos from fertility clinics have been used to establish several embryonic stem cell lines that replicate continuously in the laboratory. One cell line, known as RC-7, has been successfully converted into mature red blood cells, however tests have shown that the line of cells is not the O-negative universal donor.

Professor Turner said there are still technical problems with the technique, such as the ability of the red cells to eject their nucleii correctly, but he hopes to begin clinical trials in two or three years.

Independent Comment
blog comments powered by Disqus
Career Services

Day In a Page

The weirdest and most wonderful Diamond Jubilee memorabilia

Weird and wonderful Jubilee memorabilia

Coronation Chicken ice cream and Jubilee jelly moulds
'I may be deaf, but you can still talk to me'

'I may be deaf, but you can still talk to me'

Being a teenager is hard enough – for those with hearing loss, it can be even more complicated
A right royal trip down the river

A right royal trip down the river

A new exhibition celebrates the glory days of London's mighty Thames
The 10 Best lawn mowers

The 10 Best lawn mowers

From petrol-fuelled to self-propelled
Every second counts

Why does life appear to speed up as we get older?

Matilda Battersby finds out how the clock plays tricks with our minds
Couture on the Croisette: Fashion hits

Couture on the Croisette

The best outfits from the 2012 Cannes Film Festival
Child of the revolution: the Burmese family that democracy brought back together

Home of the free

The Burmese family that democracy brought back together
Cannes review: Canine accolade and Hitler's return are high spots amid the gloom

Cannes review

Frocks, canine accolade and Hitler's return
Robert Fisk: The going price of getting away with murder... would $33m be enough?

The going price of getting away with murder

Robert Fisk: The long view
Principled Skinner rises above the fray

Principled Skinner rises above the fray

Andy McSmith meets Dennis Skinner
Patrick Cockburn: I fear this terrible massacre will be the beginning of a long civil war in Syria

Patrick Cockburn

I fear this terrible massacre will be the beginning of a long civil war in Syria
Hardeep Singh Kohli: For me, it is all about 'Gregory's Girl', a record of first love

Hardeep Singh Kohli

For me, it is all about 'Gregory's Girl', a record of first love
Christian Louboutin: 'I don't think comfort equals happiness'

Christian Louboutin interview

'I don't think comfort equals happiness'
Happy birthday, Hotel Babylon!

Happy birthday, Hotel Babylon!

Hollywood's home to the A-list celebrates 100 years of discreet luxury
Rupert Cornwell: Low-rise capital could finally reach for the sky

Rupert Cornwell: Out of America

Low-rise capital could finally reach for the sky